首页 > 最新文献

Digestive Endoscopy最新文献

英文 中文
Endoscopist and Patients' Values and Preferences on Artificial Intelligence in Endoscopy: An Intercontinental Opinion Survey by the World Endoscopy Organization 内镜医师和患者对内镜人工智能的价值观和偏好:世界内镜组织的洲际意见调查。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-20 DOI: 10.1111/den.70123
O. F. Ahmad, A. de Groof, A. Ali, P. Bassett, M. Engels, S. Hoogenboom, N. Coelho-Prabhu, H. Yu, M. Mwachiro, S. Parasa, R. Mansilla Vivar, J. Mushtaq, H. Neumann, S. Thakkar, M. F. Byrne, J. E. van Hooft, T. Yano, Y. Mori

Background and Aims

Artificial intelligence (AI) is increasingly integrated into gastrointestinal (GI) endoscopy, yet limited data exist on how patients and endoscopists perceive its use. This study aimed to evaluate users' values and preferences regarding AI in endoscopy to support effective implementation and inform guideline development.

Methods

As part of the World Endoscopy Organization (WEO) AI committee initiatives, two structured international surveys were conducted—one for patients and one for practicing endoscopists. Thirteen AI-related statements were presented to patients via an established online platform, while 23 statements were shared with endoscopists through professional networks. Responses were captured using 5-point Likert scales and analyzed with non-parametric tests, including subgroup comparisons by age, gender, and endoscopic experience.

Results

A total of 1237 patients and 476 endoscopists participated. Most patients supported AI in image analysis (75.5%) but emphasized the need for endoscopist oversight (92.3%). Among endoscopists, 90.3% believed AI improves endoscopy quality, and 85.3% believed it benefits outcomes. Concerns were raised about liability (47%), operator dependency (34.8%), and procedure time (49%). Most respondents felt primary responsibility for AI-related errors should rest with the endoscopist. Younger and male patients reported greater trust in AI.

Conclusions

Patients and endoscopists are generally supportive of AI in GI endoscopy, especially as an adjunct to human expertise. However, key concerns—including accountability, trust, and clinical integration—must be addressed to ensure responsible and effective adoption.

背景和目的:人工智能(AI)越来越多地集成到胃肠道(GI)内窥镜检查中,但关于患者和内窥镜医生如何看待其使用的数据有限。本研究旨在评估用户对人工智能在内窥镜检查中的价值和偏好,以支持有效实施并为指南制定提供信息。方法:作为世界内窥镜组织(WEO)人工智能委员会倡议的一部分,进行了两项结构化的国际调查-一项针对患者,一项针对执业内窥镜医师。通过建立的在线平台向患者提供13个与人工智能相关的陈述,同时通过专业网络与内窥镜医师分享23个陈述。采用5点李克特量表捕获应答,并采用非参数检验进行分析,包括按年龄、性别和内窥镜经验进行亚组比较。结果:共有1237名患者和476名内镜医师参与。大多数患者支持人工智能进行图像分析(75.5%),但强调需要内镜医师的监督(92.3%)。在内窥镜医师中,90.3%的人认为人工智能提高了内窥镜检查质量,85.3%的人认为人工智能有利于结果。对责任(47%)、操作者依赖性(34.8%)和手术时间(49%)的担忧增加。大多数受访者认为人工智能相关错误的主要责任应由内窥镜医师承担。年轻和男性患者对人工智能的信任度更高。结论:患者和内窥镜医师普遍支持人工智能在胃肠道内窥镜检查中的应用,特别是作为人类专业技术的辅助。然而,关键问题——包括问责制、信任和临床整合——必须得到解决,以确保负责任和有效的采用。
{"title":"Endoscopist and Patients' Values and Preferences on Artificial Intelligence in Endoscopy: An Intercontinental Opinion Survey by the World Endoscopy Organization","authors":"O. F. Ahmad,&nbsp;A. de Groof,&nbsp;A. Ali,&nbsp;P. Bassett,&nbsp;M. Engels,&nbsp;S. Hoogenboom,&nbsp;N. Coelho-Prabhu,&nbsp;H. Yu,&nbsp;M. Mwachiro,&nbsp;S. Parasa,&nbsp;R. Mansilla Vivar,&nbsp;J. Mushtaq,&nbsp;H. Neumann,&nbsp;S. Thakkar,&nbsp;M. F. Byrne,&nbsp;J. E. van Hooft,&nbsp;T. Yano,&nbsp;Y. Mori","doi":"10.1111/den.70123","DOIUrl":"10.1111/den.70123","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Aims</h3>\u0000 \u0000 <p>Artificial intelligence (AI) is increasingly integrated into gastrointestinal (GI) endoscopy, yet limited data exist on how patients and endoscopists perceive its use. This study aimed to evaluate users' values and preferences regarding AI in endoscopy to support effective implementation and inform guideline development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>As part of the World Endoscopy Organization (WEO) AI committee initiatives, two structured international surveys were conducted—one for patients and one for practicing endoscopists. Thirteen AI-related statements were presented to patients via an established online platform, while 23 statements were shared with endoscopists through professional networks. Responses were captured using 5-point Likert scales and analyzed with non-parametric tests, including subgroup comparisons by age, gender, and endoscopic experience.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 1237 patients and 476 endoscopists participated. Most patients supported AI in image analysis (75.5%) but emphasized the need for endoscopist oversight (92.3%). Among endoscopists, 90.3% believed AI improves endoscopy quality, and 85.3% believed it benefits outcomes. Concerns were raised about liability (47%), operator dependency (34.8%), and procedure time (49%). Most respondents felt primary responsibility for AI-related errors should rest with the endoscopist. Younger and male patients reported greater trust in AI.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Patients and endoscopists are generally supportive of AI in GI endoscopy, especially as an adjunct to human expertise. However, key concerns—including accountability, trust, and clinical integration—must be addressed to ensure responsible and effective adoption.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12921463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146230030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Full Implementation of Universal Cold Snare Polypectomy for Diminutive and Small Polyps at Colonoscopy on Carbon Footprint 在结肠镜检查中全面实施小息肉冷圈套切除术对碳足迹的影响。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-18 DOI: 10.1111/den.70125
Hao-Yu Wu, Wen-Feng Hsu, Li-Chun Chang, Wei-Yuan Chang, Hsuan-Ho Lin, Chen-Ya Kuo, Ming-Shiang Wu, Han-Mo Chiu

Background and Aims

Colonoscopy significantly impacts healthcare's carbon footprint, and although cold snare polypectomy (CSP) offers a safer, more efficient method for small polyp removal, its environmental impact remains unclear. This study compares carbon footprints between the forceps plus hot snare polypectomy (HSP) versus the universal CSP strategy for subcentimetric polyps.

Methods

This retrospective analysis compared two distinct polypectomy strategies: forceps plus HSP, involving biopsy removal for diminutive adenomas and HSP for small adenomas, and universal CSP for adenomas smaller than 10 mm. A life cycle assessment evaluated the environmental impacts of endoscopy procedures, with parameters obtained from our previous pragmatic trial and empirical hospital data in 2022. Sensitivity analyses were conducted to assess the robustness of greenhouse gas (GHG) emissions estimates.

Results

The universal CSP strategy generated 22.08 kg of carbon dioxide equivalents (CO2e) per colonoscopy, a 5.30% (95% CI 4.71%–5.89%) reduction compared with 23.32 kg CO2e for the forceps plus HSP strategy. Based on 15,177 colonoscopies performed in 2022, including 5599 polypectomies, transitioning to universal CSP would reduce an institution's annual GHG emissions by an estimated 6915 kg CO2e.

Conclusions

Adopting a universal CSP strategy for subcentimetric polyps offers a significant environmental benefit alongside established clinical advantages. This single transition could cut procedural emissions by over 5% and substantially reduce the annual carbon footprint of endoscopy units, equivalent to the emissions from over 19,700 miles of passenger car travel. Our findings establish CSP as a key strategy for promoting sustainable healthcare.

背景和目的:结肠镜检查显著影响医疗保健的碳足迹,尽管冷陷阱息肉切除术(CSP)提供了一种更安全、更有效的小息肉切除方法,但其对环境的影响尚不清楚。本研究比较了钳加热陷阱息肉切除术(HSP)与通用CSP策略治疗亚厘米息肉之间的碳足迹。方法:回顾性分析比较了两种不同的息肉切除术策略:钳加HSP,包括活检切除小腺瘤和小腺瘤的HSP,以及小于10mm的腺瘤的通用CSP。生命周期评估评估了内窥镜手术的环境影响,参数来自我们之前的实用试验和2022年的经验医院数据。进行敏感性分析以评估温室气体(GHG)排放估算的稳健性。结果:通用CSP策略每次结肠镜检查产生22.08 kg二氧化碳当量(CO2e),与钳加HSP策略的23.32 kg CO2e相比减少5.30% (95% CI 4.71%-5.89%)。根据2022年进行的15,177例结肠镜检查,包括5599例息肉切除术,向通用CSP过渡将使一个机构的年度温室气体排放量减少约6915公斤二氧化碳当量。结论:采用通用的CSP策略治疗亚厘米息肉具有显著的环境效益和既定的临床优势。这一转变可以减少5%以上的程序性排放,大大减少内窥镜装置每年的碳足迹,相当于乘用车行驶超过19,700英里的排放量。我们的研究结果表明,CSP是促进可持续医疗保健的关键战略。
{"title":"Impact of Full Implementation of Universal Cold Snare Polypectomy for Diminutive and Small Polyps at Colonoscopy on Carbon Footprint","authors":"Hao-Yu Wu,&nbsp;Wen-Feng Hsu,&nbsp;Li-Chun Chang,&nbsp;Wei-Yuan Chang,&nbsp;Hsuan-Ho Lin,&nbsp;Chen-Ya Kuo,&nbsp;Ming-Shiang Wu,&nbsp;Han-Mo Chiu","doi":"10.1111/den.70125","DOIUrl":"10.1111/den.70125","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Aims</h3>\u0000 \u0000 <p>Colonoscopy significantly impacts healthcare's carbon footprint, and although cold snare polypectomy (CSP) offers a safer, more efficient method for small polyp removal, its environmental impact remains unclear. This study compares carbon footprints between the forceps plus hot snare polypectomy (HSP) versus the universal CSP strategy for subcentimetric polyps.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective analysis compared two distinct polypectomy strategies: forceps plus HSP, involving biopsy removal for diminutive adenomas and HSP for small adenomas, and universal CSP for adenomas smaller than 10 mm. A life cycle assessment evaluated the environmental impacts of endoscopy procedures, with parameters obtained from our previous pragmatic trial and empirical hospital data in 2022. Sensitivity analyses were conducted to assess the robustness of greenhouse gas (GHG) emissions estimates.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The universal CSP strategy generated 22.08 kg of carbon dioxide equivalents (CO<sub>2</sub>e) per colonoscopy, a 5.30% (95% CI 4.71%–5.89%) reduction compared with 23.32 kg CO<sub>2</sub>e for the forceps plus HSP strategy. Based on 15,177 colonoscopies performed in 2022, including 5599 polypectomies, transitioning to universal CSP would reduce an institution's annual GHG emissions by an estimated 6915 kg CO<sub>2</sub>e.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Adopting a universal CSP strategy for subcentimetric polyps offers a significant environmental benefit alongside established clinical advantages. This single transition could cut procedural emissions by over 5% and substantially reduce the annual carbon footprint of endoscopy units, equivalent to the emissions from over 19,700 miles of passenger car travel. Our findings establish CSP as a key strategy for promoting sustainable healthcare.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146215044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minor Papilla Pancreatic Duct Drainage Using a Novel Device Delivery System and Internalization of Endoscopic Nasal Pancreatic Drainage Tube With a Loop Cutter for Pancreatic Pleural Fistula in a Patient With Pancreatic Divisum 应用新型装置输送系统进行小乳头胰管引流及内化内镜下鼻胰引流管及环切器治疗胰分裂患者胰胸膜瘘。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-18 DOI: 10.1111/den.70118
Takafumi Mie, Tsuyoshi Takeda, Naoki Sasahira

Pancreatic pleural fistula (PPF) is a rare but potentially life-threatening complication. It is most associated with chronic pancreatitis [1], whereas pancreatic cancer–related PPF is uncommon. Although endoscopic treatment has been reported to be effective for PPF [2], pancreatic duct drainage in cases with pancreatic divisum remains technically challenging [3]. Although the usefulness of stent placement using a novel designed device delivery system (EndoSheather; Piolax Medical Device, Kanagawa, Japan) [4] and internalization of endoscopic nasal biliary drainage tube using a loop cutter [5] have been reported, there are no reports describing their use for pancreatic duct drainage.

A 67-year-old woman receiving chemotherapy for pancreatic cancer developed rupture of a pancreatic pseudocyst one month after chemotherapy initiation. Two months later, massive left-sided pleural effusion developed, and the patient was admitted to the hospital with dyspnea. A chest tube was inserted, and fluid analysis showed elevated amylase levels (> 60,000 IU/L). Previous computed tomography demonstrated a pancreatic duct stricture in the pancreatic body and pancreatic divisum (Figure 1).

Endoscopic retrograde cholangiopancreatography was performed, and cannulation of the minor papilla was achieved. However, advancement of the catheter and 5-Fr endoscopic nasal pancreatic drainage (ENPD) tube beyond the stricture was difficult. Then, a device delivery system enabled passage through stricture. The ENPD tube was advanced through the device, enabling placement of the ENPD tube beyond the stricture. The chest tube was removed 5 days after ERCP, and the ENPD tube was internalized 1 week later using a loop cutter. No procedure-related adverse events occurred, and PPF did not recur (Figure 2, Video S1).

When an ENPD tube placement is difficult due to severe pancreatic duct stricture, especially with pancreatic divisum, the use of a device delivery system allows reliable placement of an ENPD tube across the stricture and internalization of an ENPD tube with a loop cutter may be useful.

Conception: T.M. and T.T.; acquisition: T.M.; drafting the work: T.M.; revising: T.T. and N.S.; final approval: N.S.; all authors have read and agreed to the published this version of the manuscript.

The authors have nothing to report.

The authors declare no conflicts of interest.

胰胸膜瘘(PPF)是一种罕见但可能危及生命的并发症。它与慢性胰腺炎最相关,而与胰腺癌相关的PPF并不常见。尽管内镜治疗已被报道对PPF[2]有效,但胰腺分裂病例的胰管引流在技术上仍然具有挑战性[3]。尽管使用一种新设计的设备递送系统(EndoSheather; Piolax Medical device, Kanagawa, Japan)[4]放置支架和使用环切器[5]内化内镜鼻胆道引流管的有用性已被报道,但没有报道描述它们用于胰管引流。一位67岁的女性接受胰腺癌化疗,化疗开始一个月后出现胰腺假性囊肿破裂。两个月后,出现大量左侧胸腔积液,患者因呼吸困难入院。插入胸管,液体分析显示淀粉酶水平升高(60,000 IU/L)。先前的计算机断层扫描显示胰腺体和胰腺分裂有胰管狭窄(图1)。内镜逆行胰胆管造影,小乳头插管成功。然而,将导管和5-Fr内镜下鼻胰引流管(ENPD)推进到狭窄之外是困难的。然后,器件传送系统使通过结构成为可能。将ENPD管通过该装置推进,使ENPD管能够放置在狭窄部位之外。ERCP术后5天拔除胸管,1周后用切环器内化ENPD管。无手术相关不良事件发生,PPF未复发(图2,视频S1)。当由于严重的胰管狭窄(特别是胰分裂)而难以放置ENPD管时,使用设备输送系统可以可靠地将ENPD管放置在狭窄的地方,并且使用环切器将ENPD管内置于可能是有用的。概念:T.M.和T.T.;收购:T.M.;起草工作:T.M.;修订:T.T.和N.S.;最终批准:N.S.;所有作者已阅读并同意发表此版本的手稿。作者没有什么可报告的。作者声明无利益冲突。
{"title":"Minor Papilla Pancreatic Duct Drainage Using a Novel Device Delivery System and Internalization of Endoscopic Nasal Pancreatic Drainage Tube With a Loop Cutter for Pancreatic Pleural Fistula in a Patient With Pancreatic Divisum","authors":"Takafumi Mie,&nbsp;Tsuyoshi Takeda,&nbsp;Naoki Sasahira","doi":"10.1111/den.70118","DOIUrl":"10.1111/den.70118","url":null,"abstract":"<p>Pancreatic pleural fistula (PPF) is a rare but potentially life-threatening complication. It is most associated with chronic pancreatitis [<span>1</span>], whereas pancreatic cancer–related PPF is uncommon. Although endoscopic treatment has been reported to be effective for PPF [<span>2</span>], pancreatic duct drainage in cases with pancreatic divisum remains technically challenging [<span>3</span>]. Although the usefulness of stent placement using a novel designed device delivery system (EndoSheather; Piolax Medical Device, Kanagawa, Japan) [<span>4</span>] and internalization of endoscopic nasal biliary drainage tube using a loop cutter [<span>5</span>] have been reported, there are no reports describing their use for pancreatic duct drainage.</p><p>A 67-year-old woman receiving chemotherapy for pancreatic cancer developed rupture of a pancreatic pseudocyst one month after chemotherapy initiation. Two months later, massive left-sided pleural effusion developed, and the patient was admitted to the hospital with dyspnea. A chest tube was inserted, and fluid analysis showed elevated amylase levels (&gt; 60,000 IU/L). Previous computed tomography demonstrated a pancreatic duct stricture in the pancreatic body and pancreatic divisum (Figure 1).</p><p>Endoscopic retrograde cholangiopancreatography was performed, and cannulation of the minor papilla was achieved. However, advancement of the catheter and 5-Fr endoscopic nasal pancreatic drainage (ENPD) tube beyond the stricture was difficult. Then, a device delivery system enabled passage through stricture. The ENPD tube was advanced through the device, enabling placement of the ENPD tube beyond the stricture. The chest tube was removed 5 days after ERCP, and the ENPD tube was internalized 1 week later using a loop cutter. No procedure-related adverse events occurred, and PPF did not recur (Figure 2, Video S1).</p><p>When an ENPD tube placement is difficult due to severe pancreatic duct stricture, especially with pancreatic divisum, the use of a device delivery system allows reliable placement of an ENPD tube across the stricture and internalization of an ENPD tube with a loop cutter may be useful.</p><p>Conception: T.M. and T.T.; acquisition: T.M.; drafting the work: T.M.; revising: T.T. and N.S.; final approval: N.S.; all authors have read and agreed to the published this version of the manuscript.</p><p>The authors have nothing to report.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70118","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146222123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Are the Future Research Priorities Regarding Biliary Cannulation? How Can It Be Mastered? What Is the Most Crucial Factor? 胆道插管未来的研究重点是什么?如何掌握它?什么是最关键的因素?
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-17 DOI: 10.1111/den.70093
Mamoru Takenaka, Masatoshi Kudo
<p>Biliary cannulation is a fundamental technique in endoscopic retrograde cholangiopancreatography (ERCP) and is essential for all therapeutic and diagnostic procedures associated with ERCP. ERCP-related procedures have made remarkable progress over more than 50 years since their development, benefiting from innovations in techniques and device development [<span>1, 2</span>]. However, failure to achieve biliary cannulation renders further procedures impossible. Prolonged biliary cannulation time is a high-risk factor for post-ERCP pancreatitis (PEP) and may adversely affect patient prognosis [<span>3</span>].</p><p>Therefore, mastering biliary cannulation is the primary objective for endoscopists performing ERCP; however, it remains a significant challenge, and achieving a success rate exceeding 95% remains unresolved. With increasing experience, most endoscopists can eventually succeed in biliary cannulation. However, endoscopists who perform biliary cannulation without establishing a strategy and without evidence will never be able to overcome difficult cases. Cannulation of a native or intact papilla fails in approximately 5%–11% of cases, even in experienced hands [<span>4, 5</span>].</p><p>One of the main reasons for this challenge is the lack of a standardized technique and uniform teaching methods for biliary cannulation. Cannulation techniques include contrast-assisted, guidewire-assisted, and hybrid approaches. When initial attempts fail, multiple rescue techniques such as the double-guidewire (DGW) technique or precut sphincterotomy can be employed. Preferences for these techniques vary among both trainees and trainers, resulting in a biased and heterogeneous transfer of skills. This variability makes the creation of comprehensive, universally accepted guidelines difficult, and such guidelines remain insufficient.</p><p>In latest digestive endoscopy, new guidelines led by the World Endoscopy Organization (WEO), involving expert panels from Asia, Europe, and the United States, have been published [<span>6</span>]. The most distinctive feature of this guideline is their aim to provide globally applicable clinical recommendations, regardless of available resources or expertise. The guideline developers paid particular attention to integrating all available techniques for biliary cannulation, making it a clinically practical and useful resource worldwide.</p><p>The document is structured around four major themes: prevention of PEP, biliary cannulation techniques, endoscopic sphincterotomy and balloon dilation, and cannulation in special situations. Fourteen clinical questions (CQs) were formulated, each accompanied by a statement and supporting evidence. Although the explanations are concise, they incorporate extensive evidence, providing valuable insights into the current evidence-based status of biliary cannulation.</p><p>One of the most appealing features of these guidelines is the comprehensive summary of meta-analyses of randomized c
胆道插管是内窥镜逆行胆管造影(ERCP)的一项基本技术,对所有与ERCP相关的治疗和诊断程序都是必不可少的。得益于技术和设备发展的创新,与ercp相关的手术在50多年的发展中取得了显著的进步[1,2]。然而,未能实现胆道插管使得进一步的手术变得不可能。延长胆道插管时间是ercp后胰腺炎(PEP)的高危因素,并可能对患者预后产生不利影响。因此,掌握胆道插管是内窥镜医师实施ERCP的首要目标;然而,这仍然是一个重大挑战,实现超过95%的成功率仍然没有解决。随着经验的增加,大多数内窥镜医生最终都能成功地进行胆道插管。然而,在没有建立策略和证据的情况下进行胆道插管的内窥镜医师将永远无法克服困难的病例。原生或完整乳头的插管失败率约为5%-11%,即使是经验丰富的人[4,5]。造成这一挑战的主要原因之一是缺乏标准化的技术和统一的胆道插管教学方法。插管技术包括造影剂辅助、导丝辅助和混合入路。当最初的尝试失败时,可以采用多种救援技术,如双导丝(DGW)技术或预切括约肌切开术。受训者和培训者对这些技术的偏好各不相同,导致有偏见和异质性的技能转移。这种可变性使得制定全面的、普遍接受的指导方针变得困难,而且这样的指导方针仍然不够。在最新的消化内窥镜检查中,由世界内窥镜检查组织(World endoscopy Organization, WEO)牵头,由来自亚洲、欧洲和美国的专家小组参与的新指南已于2010年出版。本指南最显著的特点是其目的是提供全球适用的临床建议,无论现有资源或专业知识如何。指南的制定者特别注意整合所有可用的胆道插管技术,使其成为临床实用和有用的全球资源。该文件围绕四个主要主题:预防PEP,胆道插管技术,内窥镜括约肌切开术和球囊扩张,以及特殊情况下的插管。制定了14个临床问题(CQs),每个问题都附有声明和支持证据。虽然这些解释很简洁,但它们包含了广泛的证据,为目前胆道插管的循证状态提供了有价值的见解。这些指南最吸引人的特点之一是对随机对照试验(rct)的荟萃分析进行了全面总结,作为Crinò等人的补充表。这些表格本身就是极具教育意义和必不可少的读物。此外,指南报告了世界经济展望研究委员会成员中“非常同意”和“同意”回应的比例,说明了共识的程度。值得注意的是,一些声明有超过90%的“强烈同意”,而另一些则低至20%,反映了胆道插管技术固有的可变性和多样性。总的来说,这些陈述在临床上是可以接受的,并为支持许多传统上基于经验而不是数据的现实技术提供了证据。这些技术是高度专业化的,并不是普遍可用的。随着未来随机对照试验的证据积累,及时转诊到大容量中心进行这些复杂手术的重要性可能会增加。目前,有许多关于ERCP的优秀教育资源,包括教科书、演示和实践研讨会。然而,这些教育工具的最佳整合仍未得到充分探索。为结构化和有效的教学策略提供证据是我们这个领域的重要责任。胆道插管的基本原则是明确的。该过程始于彻底的准备,以最大限度地提高植入前的成功率,然后是温和的植入。在范围拉伸后到达乳头后,必须确保乳头的最佳正面视图,并仔细观察乳头和口腔突出部分,以可视化看不见的胆汁和胰管汇合处。此外,内窥镜医师必须评估内镜的形状,并根据指南陈述,轻轻地接近乳头。正如指南作者所强调的,这些建议必须在每个患者个体的背景下进行解释,并不是所有的陈述都是普遍适用的。最重要的是,温柔和谨慎的操作是至关重要的。
{"title":"What Are the Future Research Priorities Regarding Biliary Cannulation? How Can It Be Mastered? What Is the Most Crucial Factor?","authors":"Mamoru Takenaka,&nbsp;Masatoshi Kudo","doi":"10.1111/den.70093","DOIUrl":"10.1111/den.70093","url":null,"abstract":"&lt;p&gt;Biliary cannulation is a fundamental technique in endoscopic retrograde cholangiopancreatography (ERCP) and is essential for all therapeutic and diagnostic procedures associated with ERCP. ERCP-related procedures have made remarkable progress over more than 50 years since their development, benefiting from innovations in techniques and device development [&lt;span&gt;1, 2&lt;/span&gt;]. However, failure to achieve biliary cannulation renders further procedures impossible. Prolonged biliary cannulation time is a high-risk factor for post-ERCP pancreatitis (PEP) and may adversely affect patient prognosis [&lt;span&gt;3&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;Therefore, mastering biliary cannulation is the primary objective for endoscopists performing ERCP; however, it remains a significant challenge, and achieving a success rate exceeding 95% remains unresolved. With increasing experience, most endoscopists can eventually succeed in biliary cannulation. However, endoscopists who perform biliary cannulation without establishing a strategy and without evidence will never be able to overcome difficult cases. Cannulation of a native or intact papilla fails in approximately 5%–11% of cases, even in experienced hands [&lt;span&gt;4, 5&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;One of the main reasons for this challenge is the lack of a standardized technique and uniform teaching methods for biliary cannulation. Cannulation techniques include contrast-assisted, guidewire-assisted, and hybrid approaches. When initial attempts fail, multiple rescue techniques such as the double-guidewire (DGW) technique or precut sphincterotomy can be employed. Preferences for these techniques vary among both trainees and trainers, resulting in a biased and heterogeneous transfer of skills. This variability makes the creation of comprehensive, universally accepted guidelines difficult, and such guidelines remain insufficient.&lt;/p&gt;&lt;p&gt;In latest digestive endoscopy, new guidelines led by the World Endoscopy Organization (WEO), involving expert panels from Asia, Europe, and the United States, have been published [&lt;span&gt;6&lt;/span&gt;]. The most distinctive feature of this guideline is their aim to provide globally applicable clinical recommendations, regardless of available resources or expertise. The guideline developers paid particular attention to integrating all available techniques for biliary cannulation, making it a clinically practical and useful resource worldwide.&lt;/p&gt;&lt;p&gt;The document is structured around four major themes: prevention of PEP, biliary cannulation techniques, endoscopic sphincterotomy and balloon dilation, and cannulation in special situations. Fourteen clinical questions (CQs) were formulated, each accompanied by a statement and supporting evidence. Although the explanations are concise, they incorporate extensive evidence, providing valuable insights into the current evidence-based status of biliary cannulation.&lt;/p&gt;&lt;p&gt;One of the most appealing features of these guidelines is the comprehensive summary of meta-analyses of randomized c","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12912949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146215087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward a Standardized Severity Assessment in Intestinal Behçet's Disease: Reflections on the Proposal of the SCIBD Criteria 迈向肠道内分泌系统疾病严重程度的标准化评估:对SCIBD标准提出的思考
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-17 DOI: 10.1111/den.70124
Teppei Omori
<p>Behçet's disease (BD) is a complex multi-organ inflammatory disorder characterized by recurrent oral aphthous ulcers, ocular lesions, genital ulcers, skin manifestations, and various systemic symptoms. Among its clinical manifestations, intestinal BD poses significant therapeutic challenges owing to its diverse symptoms, unpredictable disease course, and potential for serious complications, such as perforation and massive bleeding. Accurate and rapid assessment of disease severity is crucial to make effective treatment strategy decisions and predict patient prognosis.</p><p>A recent multicenter study by Fukui et al. [<span>1</span>] represents an important step toward standardizing disease severity assessment. The authors proposed new severity criteria for intestinal Behçet's disease (SCIBD) based on five parameters: abdominal pain, abdominal tenderness, intestinal bleeding, serum C-reactive protein (CRP) levels, and endoscopic findings. They validated the clinical utility in a nationwide cohort comprising 14 institutions across Japan. This study represents the first attempt to integrate an objective endoscopic assessment of intestinal BD into a formal severity classification system, bridging the gap between clinical symptoms, biomarker values, and treatment decisions.</p><p>The SCIBD criteria provide a framework for the clinical evaluation of intestinal BD. Although the conventional disease activity index for intestinal Behçet's disease (DAIBD) [<span>2</span>, pp. 605–613] is a useful tool for assessing disease activity, it is primarily symptom-based and lacks elements for endoscopic evaluation. Fukui et al. addressed this limitation by incorporating endoscopic ulcer grades into the definition of ulcer severity: grade 1 (aphthae and ulcers < 1 cm), grade 2 (well-demarcated shallow ulcers ≥ 1 cm), and grade 3 (deep [mining] ulcers). Deep [mining] ulcers, characteristic of intestinal-type BD, are key indicators of severe disease. This approach is critically important because it emphasizes direct visualization of mucosal lesions. This is because deep ulcers are known predictors of poor prognosis and complications such as perforation [<span>3</span>, pp. 635–640].</p><p>The main findings of this study were the consistent correlations between the severity classification based on the SCIBD and established inflammatory markers such as CRP, erythrocyte sedimentation rate, serum albumin, and DAIBD score. Importantly, the treatment patterns aligned with the defined severity based on the SCIBD. Anti-TNF-α therapy was more frequently used in severe cases (49.4%) than in moderate cases (20.8%), and surgical intervention was more common in patients classified as severe. These findings are consistent with current treatment guidelines that recommend more aggressive therapy for severe cases [<span>4</span>, pp. 679–700].</p><p>Furthermore, the multicenter retrospective study design involving 146 patients, including those with intestinal BD and simple ulce
behet病(BD)是一种复杂的多器官炎症性疾病,其特征是复发性口腔溃疡、眼部病变、生殖器溃疡、皮肤表现和各种全身症状。在其临床表现中,肠道BD因其症状多样,病程难以预测,且可能出现穿孔、大出血等严重并发症,给治疗带来了重大挑战。准确、快速地评估疾病严重程度对于制定有效的治疗策略和预测患者预后至关重要。Fukui等人最近进行的一项多中心研究表明,朝着标准化疾病严重程度评估迈出了重要的一步。作者提出了基于5个参数的肠behet病(SCIBD)的新的严重程度标准:腹痛、腹部压痛、肠出血、血清c反应蛋白(CRP)水平和内镜检查结果。他们在日本14家机构组成的全国队列中验证了临床效用。该研究首次尝试将肠道BD的客观内镜评估整合到正式的严重程度分类系统中,弥合了临床症状、生物标志物值和治疗决策之间的差距。SCIBD标准为肠道BD的临床评估提供了一个框架。尽管肠道behet病的常规疾病活动性指数(DAIBD) [2, pp. 605-613]是评估疾病活动性的有用工具,但它主要是基于症状的,缺乏内镜评估的要素。Fukui等人通过将内窥镜溃疡分级纳入溃疡严重程度的定义来解决这一局限性:1级(溃疡和溃疡≥1厘米),2级(界限清晰的浅溃疡≥1厘米),3级(深部溃疡)。深部溃疡是肠型BD的特征,是病情严重的关键指标。这种方法非常重要,因为它强调直接观察粘膜病变。这是因为深度溃疡是已知的不良预后和并发症(如穿孔)的预测因子[3,第635-640页]。本研究的主要发现是基于SCIBD的严重程度分类与已建立的炎症标志物(如CRP、红细胞沉降率、血清白蛋白和DAIBD评分)之间存在一致的相关性。重要的是,治疗模式与基于SCIBD定义的严重程度一致。抗tnf -α治疗在重症患者(49.4%)中比在中度患者(20.8%)中更常见,手术干预在重症患者中更常见。这些发现与目前的治疗指南一致,建议对严重病例进行更积极的治疗[4,第679-700页]。此外,多中心回顾性研究设计涉及146例患者,包括肠道BD和单纯性溃疡性疾病,通过协作临床研究解决了该疾病罕见的问题。通过建立基于共识的、数据驱动的严重程度评估框架,作者为未来的前瞻性研究、临床登记和国际协调工作提供了基础。虽然这项研究具有重要的价值,但一些概念和方法上的考虑值得进一步讨论。首先,回顾性研究设计不可避免地引入了选择和回忆偏差。纳入长期病例(2006-2022年)以及内窥镜检查和生物标志物收集时间的可变性可能会影响一致性。此外,研究人群主要由中度至重度病例(约60%归为重度)组成,这可能限制了对缓解期或轻度疾病患者的推广。其次,尽管SCIBD与DAIBD和治疗强度相关,但SCIBD与DAIBD分类的符合率仅为51%。这表明,在未来的实践中,SCIBD和DAIBD可能需要被视为单独的疾病解释指标,并作为补充评分。此外,SCIBD是基于专家共识制定的,而不是使用加权参数的正式评分系统。尽管专家的共识是有价值的,一个经过验证的评分系统源自先进的统计建模可以提供更高的定量准确性和观察者之间的可靠性。第三,当仅仅依靠CRP水平作为疾病活动的指标时,应该谨慎。虽然CRP水平升高反映了炎症负担,但它们是非特异性的,可能受到肠外炎症的影响。作者恰当地指出,严重疾病不应仅仅由CRP水平升高来定义,并强调需要进行多方面的评估。第四,虽然内镜下病变分级是一个主要优势,但它涉及主观性。 溃疡的分类为“深度”或“1厘米或以上的界限清晰的浅溃疡”,并且出于安全原因,在严重病例中不进行内窥镜检查的决定可能因机构而异。最后,关键的一点是SCIBD主要关注回盲病变,这是日本肠道BD的典型和最常见的表现。然而,BD的胃肠道病变不仅可以发生在回盲区,也可以发生在食道、小肠和其他地方,可能表现为非典型病变。这些具有临床意义的病变并没有被当前的SCIBD框架所涵盖。因此,在未来的标准修订中,应将这些因素纳入SCIBD评分,作为病变程度的累积衡量指标,旨在创建一个更准确反映临床状况的评分。总之,尽管SCIBD为标准化疾病评估提供了一个重要的框架,但其改进需要前瞻性验证、更清晰的操作定义和更广泛的非典型症状。从临床角度来看,SCIBD显示了反映治疗反应性的能力,在皮质类固醇或抗tnf -α治疗后严重程度的改善支持,表明其作为反应监测工具的实用性。考虑到粘膜愈合预测肠道BD的长期预后[5,pp. 2529-2535],整合内镜下愈合状态的分类可能有助于预测预后和制定个性化护理计划。此外,在罕见疾病,如肠道双相障碍,一个一致的疾病定义是必不可少的登记发展,开展多中心研究,并协调跨试验的终点。因此,SCIBD是朝着建立肠道细菌性疾病活动通用语言迈出的关键一步。然而,作者的研究结果也强调,对全球验证和适应的需求仍未得到满足。在日本与地中海和中东等地区之间观察到的疾病表型和管理策略的差异需要跨文化协调。将SCIBD框架与欧洲风湿病协会联盟(European Alliance of Associations for Rheumatology, EULAR)领导的国际共识建立相结合[6,pp. 808-818]可能有助于建立一个真正通用的严重程度指数。此外,未来的改进应解决排除回盲区以外的疾病。由于上消化道内镜、胶囊内镜和球囊辅助肠镜检查增强了对上消化道病变(如食管溃疡)和小肠病变的发现,扩大SCIBD的内镜视野可能会拓宽其临床意义。结合整个胃肠道病变的数量、分布和形态,可以更全面地了解疾病负担。最后,前瞻性验证研究是必要的。纵向设计评估SCIBD对治疗的动态反应、复发和手术结果的预测价值以及观察者间的可重复性,将进一步加强临床可靠性。由于双相障碍是一种伴有全体性症状的复发缓解型疾病,将四种主要体征等肠外域纳入多维复合评分可能最终实现全体性双相障碍的统一严重程度评估框架。Fukui等人的多中心合作研究[1]代表了肠道双相障碍疾病评估发展的突破性成就。提供了一个更客观和临床一致的方法来定义疾病的严重程度。然而,其目前的形式,主要侧重于回盲病变,缺乏正式的评分细化,应被视为一个基础框架,而不是一个确定的框架。未来的研究应旨在通过前瞻性多中心研究来验证和完善SCIBD,同时扩大其在非典型病例和上消化道病变中的应用。通过这些努力,SCIBD有可能发展成为一个普遍接受的评估肠道双相障碍严重程度和指导个体化治疗的循证标准。大森特平(Teppei Omori)起草了第一版手稿,修改了手稿,并批准了最终版本。作者没有什么可报道的。作者没有什么可报道的。大森泰沛获得艾伯维(AbbVie) GK的讲演费。这篇文章链接到Fukui等人的论文。要查看本文,请访问https://doi.org/10.1111/den.70041。
{"title":"Toward a Standardized Severity Assessment in Intestinal Behçet's Disease: Reflections on the Proposal of the SCIBD Criteria","authors":"Teppei Omori","doi":"10.1111/den.70124","DOIUrl":"10.1111/den.70124","url":null,"abstract":"&lt;p&gt;Behçet's disease (BD) is a complex multi-organ inflammatory disorder characterized by recurrent oral aphthous ulcers, ocular lesions, genital ulcers, skin manifestations, and various systemic symptoms. Among its clinical manifestations, intestinal BD poses significant therapeutic challenges owing to its diverse symptoms, unpredictable disease course, and potential for serious complications, such as perforation and massive bleeding. Accurate and rapid assessment of disease severity is crucial to make effective treatment strategy decisions and predict patient prognosis.&lt;/p&gt;&lt;p&gt;A recent multicenter study by Fukui et al. [&lt;span&gt;1&lt;/span&gt;] represents an important step toward standardizing disease severity assessment. The authors proposed new severity criteria for intestinal Behçet's disease (SCIBD) based on five parameters: abdominal pain, abdominal tenderness, intestinal bleeding, serum C-reactive protein (CRP) levels, and endoscopic findings. They validated the clinical utility in a nationwide cohort comprising 14 institutions across Japan. This study represents the first attempt to integrate an objective endoscopic assessment of intestinal BD into a formal severity classification system, bridging the gap between clinical symptoms, biomarker values, and treatment decisions.&lt;/p&gt;&lt;p&gt;The SCIBD criteria provide a framework for the clinical evaluation of intestinal BD. Although the conventional disease activity index for intestinal Behçet's disease (DAIBD) [&lt;span&gt;2&lt;/span&gt;, pp. 605–613] is a useful tool for assessing disease activity, it is primarily symptom-based and lacks elements for endoscopic evaluation. Fukui et al. addressed this limitation by incorporating endoscopic ulcer grades into the definition of ulcer severity: grade 1 (aphthae and ulcers &lt; 1 cm), grade 2 (well-demarcated shallow ulcers ≥ 1 cm), and grade 3 (deep [mining] ulcers). Deep [mining] ulcers, characteristic of intestinal-type BD, are key indicators of severe disease. This approach is critically important because it emphasizes direct visualization of mucosal lesions. This is because deep ulcers are known predictors of poor prognosis and complications such as perforation [&lt;span&gt;3&lt;/span&gt;, pp. 635–640].&lt;/p&gt;&lt;p&gt;The main findings of this study were the consistent correlations between the severity classification based on the SCIBD and established inflammatory markers such as CRP, erythrocyte sedimentation rate, serum albumin, and DAIBD score. Importantly, the treatment patterns aligned with the defined severity based on the SCIBD. Anti-TNF-α therapy was more frequently used in severe cases (49.4%) than in moderate cases (20.8%), and surgical intervention was more common in patients classified as severe. These findings are consistent with current treatment guidelines that recommend more aggressive therapy for severe cases [&lt;span&gt;4&lt;/span&gt;, pp. 679–700].&lt;/p&gt;&lt;p&gt;Furthermore, the multicenter retrospective study design involving 146 patients, including those with intestinal BD and simple ulce","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70124","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146215102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Reappraisal of Confounding and Detection Bias in the Gastric Atrophy–ESCC Association 回复:重新评估胃萎缩- escc关联的混淆和检测偏差。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-16 DOI: 10.1111/den.70127
Kenta Watanabe, Sho Fukuda, Katsunori Iijima

We appreciate Park's thoughtful commentary on our nationwide cohort showing that extensive (open-type) endoscopic gastric atrophy (GA) is associated with higher esophageal squamous cell carcinoma (ESCC) incidence among regular screening esophagogastroduodenoscopy (EGD) examinees in Japan [1, 2].

Residual and unmeasured confounding warrant consideration. In our health check-up setting, smoking and alcohol were recorded as ever/never per the Ministry of Health, Labour and Welfare's standard questionnaire, which lacks cumulative exposure items, an acknowledged limitation [2, 3]. Even so, alcohol remained significantly associated with ESCC, and open-type GA consistently emerged as an independent risk factor (adjusted HR 2.7, 95% CI 1.6–4.7). We agree that diet, oral hygiene and socioeconomic context are relevant; future prospective designs should capture quantitative exposures and these variables systematically.

To address baseline imbalances (age, sex), we combined multiple imputation with multivariable Cox regression and prespecified subgroup analyses, adjusting for age, sex, alcohol, smoking, etc. Findings were concordant across imputed and complete case analyses and subgroups. Propensity-based methods were considered a priori but deprioritized due to few ESCC events (n = 77) and a three-category exposure, which risked unstable weights or loss of effective sample size.

Regarding detection bias, baseline GA was adjudicated independent of outcomes, incidence was expressed per person-years, and time-to-event modeling accounted for follow-up. Even in a sensitivity model additionally adjusting for the number of EGDs during follow-up, the association for open-type GA was materially unchanged (adjusted HR 2.80, 95% CI 1.64–4.80), supporting robustness.

Mechanistically plausible pathways (hypochlorhydria and oral–esophageal microbial influences) merit integrative prospective studies (microbiome, metabolomics, reflux characterization). In summary, within a large screening cohort, open-type GA remained an independent risk marker for ESCC. While residual confounding cannot be fully excluded, complete negation of the association appears unlikely; our study is hypothesis-generating and could motivate mechanistic research.

K.W. drafted the manuscript; S.F. and K.I. critically revised it. All authors approved the final version.

The authors have nothing to report.

The authors declare no conflicts of interest.

我们很欣赏Park对我们全国队列的周到评论,该队列显示,在日本定期筛查食管胃十二指肠镜(EGD)的受试者中,广泛(开放式)内窥镜胃萎缩(GA)与较高的食管鳞状细胞癌(ESCC)发病率相关[1,2]。剩余和未测量的混淆值得考虑。在我们的健康检查环境中,根据厚生劳动省的标准问卷,吸烟和饮酒被记录为“以前/从来没有”,其中缺乏累积暴露项目,这是一个公认的限制[2,3]。即便如此,酒精仍然与ESCC显著相关,开放式GA始终是独立的危险因素(调整后的HR为2.7,95% CI为1.6-4.7)。我们同意饮食、口腔卫生和社会经济背景是相关的;未来的前瞻性设计应该系统地捕获定量暴露和这些变量。为了解决基线不平衡(年龄、性别)问题,我们将多重归算与多变量Cox回归和预先指定的亚组分析相结合,调整了年龄、性别、酒精、吸烟等因素。结果在估算和完整的病例分析和亚组中是一致的。基于倾向的方法被认为是先验的,但由于ESCC事件较少(n = 77)和三类暴露,可能存在权重不稳定或有效样本量损失的风险,因此不优先考虑。关于检测偏倚,基线GA被判定为独立于结果,发病率表示为每个人年,事件时间模型用于随访。即使在敏感性模型中额外调整随访期间egd的数量,开放式GA的相关性也基本不变(调整后的HR 2.80, 95% CI 1.64-4.80),支持稳健性。机制上合理的途径(低氯血症和口腔-食管微生物影响)值得综合前瞻性研究(微生物组学、代谢组学、反流表征)。总之,在一个大的筛查队列中,开放式GA仍然是ESCC的独立风险标志。虽然残余混淆不能完全排除,但完全否定关联似乎不太可能;我们的研究是假设生成,可以激励机制研究。起草手稿;sf和K.I.对它进行了严格的修改。所有作者都认可了最终版本。作者没有什么可报告的。作者声明无利益冲突。
{"title":"Reply: Reappraisal of Confounding and Detection Bias in the Gastric Atrophy–ESCC Association","authors":"Kenta Watanabe,&nbsp;Sho Fukuda,&nbsp;Katsunori Iijima","doi":"10.1111/den.70127","DOIUrl":"10.1111/den.70127","url":null,"abstract":"<p>We appreciate Park's thoughtful commentary on our nationwide cohort showing that extensive (open-type) endoscopic gastric atrophy (GA) is associated with higher esophageal squamous cell carcinoma (ESCC) incidence among regular screening esophagogastroduodenoscopy (EGD) examinees in Japan [<span>1, 2</span>].</p><p>Residual and unmeasured confounding warrant consideration. In our health check-up setting, smoking and alcohol were recorded as ever/never per the Ministry of Health, Labour and Welfare's standard questionnaire, which lacks cumulative exposure items, an acknowledged limitation [<span>2, 3</span>]. Even so, alcohol remained significantly associated with ESCC, and open-type GA consistently emerged as an independent risk factor (adjusted HR 2.7, 95% CI 1.6–4.7). We agree that diet, oral hygiene and socioeconomic context are relevant; future prospective designs should capture quantitative exposures and these variables systematically.</p><p>To address baseline imbalances (age, sex), we combined multiple imputation with multivariable Cox regression and prespecified subgroup analyses, adjusting for age, sex, alcohol, smoking, etc. Findings were concordant across imputed and complete case analyses and subgroups. Propensity-based methods were considered a priori but deprioritized due to few ESCC events (<i>n</i> = 77) and a three-category exposure, which risked unstable weights or loss of effective sample size.</p><p>Regarding detection bias, baseline GA was adjudicated independent of outcomes, incidence was expressed per person-years, and time-to-event modeling accounted for follow-up. Even in a sensitivity model additionally adjusting for the number of EGDs during follow-up, the association for open-type GA was materially unchanged (adjusted HR 2.80, 95% CI 1.64–4.80), supporting robustness.</p><p>Mechanistically plausible pathways (hypochlorhydria and oral–esophageal microbial influences) merit integrative prospective studies (microbiome, metabolomics, reflux characterization). In summary, within a large screening cohort, open-type GA remained an independent risk marker for ESCC. While residual confounding cannot be fully excluded, complete negation of the association appears unlikely; our study is hypothesis-generating and could motivate mechanistic research.</p><p>K.W. drafted the manuscript; S.F. and K.I. critically revised it. All authors approved the final version.</p><p>The authors have nothing to report.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146208496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teaching, Not Just Detecting: The Next Chapter for AI in Endoscopy Training 教学,而不仅仅是检测:人工智能在内窥镜训练中的下一章。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-13 DOI: 10.1111/den.70122
Maria Eva Argenziano, Yuichi Mori, David J. Tate
<p>Artificial intelligence (AI) has changed the way we look at endoscopic practice. Over the past decade, it has evolved from an experimental tool into an integral part of daily endoscopy, improving accuracy and diagnostic yield. Yet while most attention has gone to how AI helps us detect more, a more pressing question is how it can help us <i>teach</i> better.</p><p>In their narrative review, Ho et al. [<span>1</span>] explore how AI has entered endoscopy training across multiple fields: luminal, hepatobiliary, capsule, and therapeutic endoscopy. They describe an impressive expansion of AI's educational footprint, but also a clear imbalance: detection is accelerating, while human learning risks falling behind.</p><p>The review outlines what could be called the “AI life cycle” of a trainee. Before procedures, AI can simulate and predict; during procedures, it can guide and correct; afterward, it can analyze performance. In reality, most published work focuses on that middle stage, the live procedure, leaving simulation and feedback relatively underdeveloped. We are still spending most of our time on detection, not on longitudinal learning.</p><p>This uneven growth is mirrored in attitudes within the endoscopic community. Many trainees welcome AI for the sense of safety and reassurance it offers, while others, often more senior, worry about overreliance and loss of skill. That tension is understandable: AI's educational value remains fragmented, with most benefits concentrated in high-income settings and early training phases.</p><p>The quantitative evidence is encouraging. In computer-aided detection (CADe) trials, adenoma detection rate has improved by roughly 13%–22% among trainees, and even more among beginners, who often reach near-expert performance in miss rate [<span>2-4</span>]. In capsule endoscopy, AI has shortened reading times and improved accuracy, although performance still falls short of experienced readers [<span>5</span>]. In EUS, studies show higher accuracy in structure recognition and shorter time to lesion identification [<span>6, 7</span>], and in therapeutic endoscopy, AI now assists with vessel and perforation recognition, potentially improving safety and speeding up learning [<span>8</span>]. These are meaningful gains, but they remain mostly procedural rather than educational.</p><p>Learning, however, involves more than precision. Few studies have measured true training outcomes such as knowledge retention, time to proficiency, or safe independent performance. The next challenge is to translate detection into durable learning.</p><p>Practical models already exist. Computer-aided quality tools that assess withdrawal time or mucosal coverage could easily form the basis of automated dashboards for feedback. Integrated with validated training curricula, these tools could provide day-to-day learning support and end-of-rotation assessment. In this way, AI can help trainees recognize more and, crucially, understand why they mis
a和d。j。t。起草了这份工作。M.E.A, y.m.和d.j.t已经批准了最终版本。作者没有什么可报道的。奥林巴斯(咨询、设备借用、讲座费)和Cybernet System(忠诚费)。D.J.T.奥林巴斯、富士胶片和宾得(咨询和研究支持)。作者声明无利益冲突。这篇文章链接到Ho等人。详情请访问https://doi.org/10.1111/den.70047。
{"title":"Teaching, Not Just Detecting: The Next Chapter for AI in Endoscopy Training","authors":"Maria Eva Argenziano,&nbsp;Yuichi Mori,&nbsp;David J. Tate","doi":"10.1111/den.70122","DOIUrl":"10.1111/den.70122","url":null,"abstract":"&lt;p&gt;Artificial intelligence (AI) has changed the way we look at endoscopic practice. Over the past decade, it has evolved from an experimental tool into an integral part of daily endoscopy, improving accuracy and diagnostic yield. Yet while most attention has gone to how AI helps us detect more, a more pressing question is how it can help us &lt;i&gt;teach&lt;/i&gt; better.&lt;/p&gt;&lt;p&gt;In their narrative review, Ho et al. [&lt;span&gt;1&lt;/span&gt;] explore how AI has entered endoscopy training across multiple fields: luminal, hepatobiliary, capsule, and therapeutic endoscopy. They describe an impressive expansion of AI's educational footprint, but also a clear imbalance: detection is accelerating, while human learning risks falling behind.&lt;/p&gt;&lt;p&gt;The review outlines what could be called the “AI life cycle” of a trainee. Before procedures, AI can simulate and predict; during procedures, it can guide and correct; afterward, it can analyze performance. In reality, most published work focuses on that middle stage, the live procedure, leaving simulation and feedback relatively underdeveloped. We are still spending most of our time on detection, not on longitudinal learning.&lt;/p&gt;&lt;p&gt;This uneven growth is mirrored in attitudes within the endoscopic community. Many trainees welcome AI for the sense of safety and reassurance it offers, while others, often more senior, worry about overreliance and loss of skill. That tension is understandable: AI's educational value remains fragmented, with most benefits concentrated in high-income settings and early training phases.&lt;/p&gt;&lt;p&gt;The quantitative evidence is encouraging. In computer-aided detection (CADe) trials, adenoma detection rate has improved by roughly 13%–22% among trainees, and even more among beginners, who often reach near-expert performance in miss rate [&lt;span&gt;2-4&lt;/span&gt;]. In capsule endoscopy, AI has shortened reading times and improved accuracy, although performance still falls short of experienced readers [&lt;span&gt;5&lt;/span&gt;]. In EUS, studies show higher accuracy in structure recognition and shorter time to lesion identification [&lt;span&gt;6, 7&lt;/span&gt;], and in therapeutic endoscopy, AI now assists with vessel and perforation recognition, potentially improving safety and speeding up learning [&lt;span&gt;8&lt;/span&gt;]. These are meaningful gains, but they remain mostly procedural rather than educational.&lt;/p&gt;&lt;p&gt;Learning, however, involves more than precision. Few studies have measured true training outcomes such as knowledge retention, time to proficiency, or safe independent performance. The next challenge is to translate detection into durable learning.&lt;/p&gt;&lt;p&gt;Practical models already exist. Computer-aided quality tools that assess withdrawal time or mucosal coverage could easily form the basis of automated dashboards for feedback. Integrated with validated training curricula, these tools could provide day-to-day learning support and end-of-rotation assessment. In this way, AI can help trainees recognize more and, crucially, understand why they mis","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70122","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Resection of a Biliary Fibrous Polyp Detected by Peroral Cholangioscopy Using a Rotatable Basket Catheter Under Fluoroscopic Guidance 经口胆道镜检查发现的胆道纤维息肉的内镜切除,在透视引导下使用可旋转的篮状导管。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-11 DOI: 10.1111/den.70119
Takahiro Urata, Shingo Ueno, Shun Kawahara

A 45-year-old woman was referred to our hospital with abdominal pain. Magnetic resonance cholangiopancreatography demonstrated a common bile duct (CBD) stone (Figure 1). Endoscopic retrograde cholangiopancreatography confirmed an impacted stone at the confluence of the cystic duct and the CBD. Because of distal bile duct narrowing, electrohydraulic lithotripsy was performed under peroral cholangioscopy (POCS), followed by stone extraction using a basket catheter. After stone removal, POCS revealed a protruding lesion at the cystic duct orifice (Figure 2). The lesion was isochromatic with the surrounding mucosa and was suspected to be an inflammatory polyp. Because its size and location made conventional cholangioscopic forceps inadequate for obtaining sufficient tissue, and direct cholangioscopic manipulation was limited by the narrow distal bile duct, the lesion was resected as a complete excisional biopsy to achieve both a definitive histopathological diagnosis and complete removal. Under fluoroscopic guidance, the lesion was gently captured with a rotatable basket catheter (RASEN2; KANEKA Medical, Japan). By carefully rotating the catheter, the lesion was detached, and complete excision was achieved without bleeding or perforation. Subsequent POCS confirmed complete resection endoscopically, with no residual lesion or procedure-related adverse events, thereby demonstrating the safety of this approach. Histopathological examination revealed an inflammatory fibrous polyp composed of fibrous stroma with mild epithelial proliferation and inflammatory cell infiltration. No recurrence was observed during follow-up [1-3]. This video demonstrates that a rotatable basket catheter, originally designed for bile duct stone extraction, can be considered a diagnostic and therapeutic option in carefully selected cases of intraductal biliary lesions when conventional cholangioscopic devices are not applicable.

T.U. contributed to the conception and design of the study, performed the endoscopic procedure, and drafted the manuscript. S.U. and S.K. contributed to data acquisition and interpretation. All authors critically revised the manuscript and approved the final version.

The authors have nothing to report.

The authors declare no conflicts of interest.

一名45岁妇女因腹痛转诊至我院。磁共振胆管造影显示胆总管(CBD)结石(图1)。内窥镜逆行胆管造影证实胆囊管和CBD汇合处有一阻生结石。由于远端胆管狭窄,在经口胆管镜(POCS)下进行电液碎石,然后使用篮状导管取出结石。取石后,POCS显示胆囊管开口处有突出病变(图2)。病变与周围粘膜呈等色,怀疑为炎性息肉。由于其大小和位置使得常规胆管镜钳无法获得足够的组织,且胆管远端狭窄限制了直接胆管镜操作,因此切除病变作为完全切除活检,以获得明确的组织病理学诊断和完全切除。在透视引导下,用可旋转篮状导管(RASEN2; KANEKA Medical, Japan)轻轻捕获病变。通过小心旋转导管,病变被分离,完全切除,无出血或穿孔。随后的POCS证实了内镜下的完全切除,没有残留病变或手术相关的不良事件,从而证明了该方法的安全性。组织病理学检查显示为炎性纤维性息肉,由纤维间质组成,伴有轻度上皮增生和炎性细胞浸润。随访期间未见复发[1-3]。本视频展示了最初设计用于胆管结石取出的可旋转篮状导管,在常规胆道镜设备不适用的情况下,可被认为是一种精心选择的导管内胆道病变的诊断和治疗选择。参与研究的构思和设计,执行内窥镜手术,并起草手稿。S.U.和S.K.对数据采集和解释作出了贡献。所有作者都严格修改了手稿,并批准了最终版本。作者没有什么可报告的。作者声明无利益冲突。
{"title":"Endoscopic Resection of a Biliary Fibrous Polyp Detected by Peroral Cholangioscopy Using a Rotatable Basket Catheter Under Fluoroscopic Guidance","authors":"Takahiro Urata,&nbsp;Shingo Ueno,&nbsp;Shun Kawahara","doi":"10.1111/den.70119","DOIUrl":"10.1111/den.70119","url":null,"abstract":"<p>A 45-year-old woman was referred to our hospital with abdominal pain. Magnetic resonance cholangiopancreatography demonstrated a common bile duct (CBD) stone (Figure 1). Endoscopic retrograde cholangiopancreatography confirmed an impacted stone at the confluence of the cystic duct and the CBD. Because of distal bile duct narrowing, electrohydraulic lithotripsy was performed under peroral cholangioscopy (POCS), followed by stone extraction using a basket catheter. After stone removal, POCS revealed a protruding lesion at the cystic duct orifice (Figure 2). The lesion was isochromatic with the surrounding mucosa and was suspected to be an inflammatory polyp. Because its size and location made conventional cholangioscopic forceps inadequate for obtaining sufficient tissue, and direct cholangioscopic manipulation was limited by the narrow distal bile duct, the lesion was resected as a complete excisional biopsy to achieve both a definitive histopathological diagnosis and complete removal. Under fluoroscopic guidance, the lesion was gently captured with a rotatable basket catheter (RASEN2; KANEKA Medical, Japan). By carefully rotating the catheter, the lesion was detached, and complete excision was achieved without bleeding or perforation. Subsequent POCS confirmed complete resection endoscopically, with no residual lesion or procedure-related adverse events, thereby demonstrating the safety of this approach. Histopathological examination revealed an inflammatory fibrous polyp composed of fibrous stroma with mild epithelial proliferation and inflammatory cell infiltration. No recurrence was observed during follow-up [<span>1-3</span>]. This video demonstrates that a rotatable basket catheter, originally designed for bile duct stone extraction, can be considered a diagnostic and therapeutic option in carefully selected cases of intraductal biliary lesions when conventional cholangioscopic devices are not applicable.</p><p>T.U. contributed to the conception and design of the study, performed the endoscopic procedure, and drafted the manuscript. S.U. and S.K. contributed to data acquisition and interpretation. All authors critically revised the manuscript and approved the final version.</p><p>The authors have nothing to report.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70119","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Magnetic Countertraction Enhanced Performance in Colonic Endoscopic Submucosal Dissection: An Ex Vivo Crossover Study (With Video) 新型磁反牵引增强结肠内镜粘膜下剥离的性能:一项离体交叉研究(带视频)。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-10 DOI: 10.1111/den.70120
Hon Chi Yip, Wai Shing Chan, Siew Fung Hau, Nicole Miu-yee Cheng, Louis Ho-Shing Lau, Simon Chu, Zhaoyi Zhu, Man Yee Yung, Yee Kit Tse, Zheng Li, Simon Siu-man Ng, Philip Wai-yan Chiu

Endoscopic submucosal dissection (ESD) is technically demanding with the main limitation on the lack of effective countertraction. Existing countertraction methods such as clip-related techniques only provide unidirectional static traction force that may restrict their utility in complicated colorectal ESD. The magnetic countertraction system provides dynamic force by manipulating an external magnetic source. We designed a novel magnetic countertraction system with an internal magnet retractor introducible via the endoscopy channel and the external magnetic effector mounted on a robotic arm that could be easily manipulated. We evaluated the performance and safety of the system in an ex vivo randomized crossover study. ESD was performed on ex vivo porcine colon models with standardized 3 cm target lesions marked at gravity-dependent locations. Endoscopists performed the ESD in pairs, randomized to magnetic countertraction (MAG-ESD) or conventional ESD (C-ESD) first to minimize bias from the learning effect. During MAG-ESD, a flexible internal magnetic retractor was deployed via the endoscopic channel and anchored to the lesion margin. A robotic arm-mounted external permanent magnet (EPM) was positioned above the colon model to engage the retractor and provide dynamic countertraction. Seventy-two ESD (36 MAG-ESD and 36 C-ESD) were performed by 18 endoscopists. MAG-ESD significantly reduced procedure time by 20.4% (p = 0.0002) and workload (NASA-TLX mean difference: −19.81, 95% CI: −25.42 to −14.19). All procedures achieved en bloc resection. MAG-ESD had significantly fewer complications (OR = 0.782, 95% CI: 0.644–0.949), including lower rates of perforation and muscle injury. The novel magnetic countertraction system significantly improved procedural efficiency, reduced operator workload, and enhanced safety in ex vivo colonic ESD.

内镜下粘膜剥离(ESD)技术要求高,主要限制在缺乏有效的反牵引。现有的反牵引方法,如夹相关技术,只能提供单向的静态牵引力,这可能会限制其在复杂结肠直肠ESD中的应用。磁反牵引系统通过操纵外部磁源提供动力。我们设计了一种新型的磁反牵引系统,该系统内部有一个可通过内窥镜通道引入的磁性牵开器,外部磁效应器安装在机械臂上,可以方便地操作。我们在一项离体随机交叉研究中评估了该系统的性能和安全性。在离体猪结肠模型上进行ESD,在重力依赖位置标记标准化的3cm靶病变。内镜医师成对进行ESD,随机分为磁力反牵引(magg -ESD)和常规ESD (C-ESD)两组,以尽量减少学习效应带来的偏差。在MAG-ESD过程中,通过内镜通道部署一个灵活的内磁牵开器并固定在病变边缘。一个安装在机械臂上的外部永磁体(EPM)被放置在结肠模型的上方,以接合牵开器并提供动态反牵引。由18名内镜医师进行72例ESD(36例MAG-ESD和36例C-ESD)。MAG-ESD显著减少了20.4%的手术时间(p = 0.0002)和工作量(NASA-TLX平均差值:-19.81,95% CI: -25.42至-14.19)。所有手术均实现整体切除。magg - esd的并发症明显减少(OR = 0.782, 95% CI: 0.644-0.949),包括穿孔和肌肉损伤的发生率较低。新型磁力反牵引系统显著提高了手术效率,减少了操作人员的工作量,并增强了离体结肠ESD的安全性。
{"title":"Novel Magnetic Countertraction Enhanced Performance in Colonic Endoscopic Submucosal Dissection: An Ex Vivo Crossover Study (With Video)","authors":"Hon Chi Yip,&nbsp;Wai Shing Chan,&nbsp;Siew Fung Hau,&nbsp;Nicole Miu-yee Cheng,&nbsp;Louis Ho-Shing Lau,&nbsp;Simon Chu,&nbsp;Zhaoyi Zhu,&nbsp;Man Yee Yung,&nbsp;Yee Kit Tse,&nbsp;Zheng Li,&nbsp;Simon Siu-man Ng,&nbsp;Philip Wai-yan Chiu","doi":"10.1111/den.70120","DOIUrl":"10.1111/den.70120","url":null,"abstract":"<p>Endoscopic submucosal dissection (ESD) is technically demanding with the main limitation on the lack of effective countertraction. Existing countertraction methods such as clip-related techniques only provide unidirectional static traction force that may restrict their utility in complicated colorectal ESD. The magnetic countertraction system provides dynamic force by manipulating an external magnetic source. We designed a novel magnetic countertraction system with an internal magnet retractor introducible via the endoscopy channel and the external magnetic effector mounted on a robotic arm that could be easily manipulated. We evaluated the performance and safety of the system in an ex vivo randomized crossover study. ESD was performed on ex vivo porcine colon models with standardized 3 cm target lesions marked at gravity-dependent locations. Endoscopists performed the ESD in pairs, randomized to magnetic countertraction (MAG-ESD) or conventional ESD (C-ESD) first to minimize bias from the learning effect. During MAG-ESD, a flexible internal magnetic retractor was deployed via the endoscopic channel and anchored to the lesion margin. A robotic arm-mounted external permanent magnet (EPM) was positioned above the colon model to engage the retractor and provide dynamic countertraction. Seventy-two ESD (36 MAG-ESD and 36 C-ESD) were performed by 18 endoscopists. MAG-ESD significantly reduced procedure time by 20.4% (<i>p</i> = 0.0002) and workload (NASA-TLX mean difference: −19.81, 95% CI: −25.42 to −14.19). All procedures achieved en bloc resection. MAG-ESD had significantly fewer complications (OR = 0.782, 95% CI: 0.644–0.949), including lower rates of perforation and muscle injury. The novel magnetic countertraction system significantly improved procedural efficiency, reduced operator workload, and enhanced safety in ex vivo colonic ESD.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12887612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
En Bloc Resection of A Giant Pedunculated Esophageal Mature Teratoma by Endoscopic Submucosal Dissection 内镜下粘膜夹层切除巨大带蒂食管成熟畸胎瘤1例。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-09 DOI: 10.1111/den.70121
Yuhang Zhang, Ruizhi Wang, Bing Hu

A 21-year-old man complained about progressive dysphagia and hoarseness for 9 months. Endoscopy revealed a giant, lobular 0-Ip mass (stalk diameter 1.5 cm) protruding into the esophageal lumen 20–28 cm from the incisors, with hair on the surface (Figure 1A). Further endoscopic ultrasonography showed that the mass was 3.92 cm × 2.66 cm, originating from submucosa, with mixed echo, clear demarcation, and intact muscularis propria (Figure 1B). Enhanced chest CT also showed a 4.3 cm × 3.2 cm × 10.7 cm mass at the esophageal wall (Figure 1C). Endoscopic submucosal dissection (ESD) of the mass was performed after the patient's consent. Under general anesthesia and intubation, standard ESD procedures were performed (Video S1) with dual knife and insulated tip knife. En bloc resection of the mass was successful, without perforation or bleeding (Figure 1D–F). The attempt to retrieve the whole mass failed. Therefore, we fragmented the mass and retrieved them using a snare (Figure 1G,H). The wound was finally closed with titanium clips (Figure 1I). The entire procedural time was 104 min. The resected mass (Figure 2A) was pathologically diagnosed as mature teratoma (Figure 2B). No residue or recurrence of the tumor was found upon visit (Figure 2C). Mediastinal teratoma are frequently reported [1], but esophageal teratoma is rare [2]. Usually, patients may be referred to surgical or thoracoscopic resection for curative treatment. Considering the benign nature and clear demarcation of the mature teratoma, ESD is advantageous for its en bloc endoscopic resection. To the best of our knowledge, endoscopic management of giant esophageal teratoma has not been reported. Although the size of the tumor was over 40 mm and the whole procedural time was 104 min, posing risk of technical difficulty of ESD [3], the actual tumor dissection time was 9 min and the stalk size was 15 mm in our case, presenting no obvious resection limitation. Our case shows ESD is feasible for esophagus-derived teratoma, and therefore, may provide a safer, cheaper, and less invasive replacement of surgical interventions [4].

Yuhang Zhang drafted the manuscript and the video clip. Ruizhi Wang collected the material and made critical revisions. Bing Hu performed the endoscopic resection and conceptualization.

This work was supported by National Natural Science Foundation of China (82170675) and 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYJC21011).

Informed consent was obtained from the patient to publish these images.

The authors declare no conflicts of interest.

一名21岁男性主诉进行性吞咽困难和声音嘶哑9个月。内窥镜显示一个巨大的0-Ip小叶状肿块(柄直径1.5 cm),突出到距门牙20-28 cm的食管腔内,表面有毛发(图1A)。进一步超声内镜检查显示肿块大小为3.92 cm × 2.66 cm,起源于粘膜下层,回声混合,界限清晰,固有肌层完整(图1B)。增强胸部CT也显示食管壁4.3 cm × 3.2 cm × 10.7 cm肿块(图1C)。经患者同意后,对肿物进行内镜下粘膜下剥离(ESD)。在全身麻醉和插管下,使用双刀和绝缘尖刀进行标准ESD操作(视频S1)。肿块整体切除成功,无穿孔或出血(图1D-F)。试图找回所有的东西失败了。因此,我们将肿块碎片化,并使用陷阱将其收回(图1G,H)。最后用钛夹缝合伤口(图1I)。整个手术时间为104分钟。切除的肿块(图2A)病理诊断为成熟畸胎瘤(图2B)。随访时未发现肿瘤残留或复发(图2C)。纵隔畸胎瘤常被报道为[1],但食管畸胎瘤是罕见的[1]。通常情况下,患者可能需要手术或胸腔镜切除以获得根治性治疗。考虑到成熟畸胎瘤的良性性质和清晰的界限,ESD有利于其整体内镜切除。据我们所知,内窥镜治疗巨大食道畸胎瘤尚未见报道。虽然肿瘤大小超过40 mm,整个手术时间为104 min,存在ESD[3]技术难度的风险,但本病例实际肿瘤清扫时间为9 min,茎节大小为15 mm,无明显切除限制。我们的病例表明,ESD治疗食管源性畸胎瘤是可行的,因此,它可能是一种更安全、更便宜、侵入性更小的手术干预替代方法[10]。张宇航起草了手稿和视频片段。王瑞芝收集了这些材料,并进行了重要的修订。胡兵进行了内镜切除和概念化。国家自然科学基金项目(82170675)和四川大学华西医院1·3·5优秀学科项目(ZYJC21011)资助。获得患者的知情同意后发表这些图像。作者声明无利益冲突。
{"title":"En Bloc Resection of A Giant Pedunculated Esophageal Mature Teratoma by Endoscopic Submucosal Dissection","authors":"Yuhang Zhang,&nbsp;Ruizhi Wang,&nbsp;Bing Hu","doi":"10.1111/den.70121","DOIUrl":"10.1111/den.70121","url":null,"abstract":"<p>A 21-year-old man complained about progressive dysphagia and hoarseness for 9 months. Endoscopy revealed a giant, lobular 0-Ip mass (stalk diameter 1.5 cm) protruding into the esophageal lumen 20–28 cm from the incisors, with hair on the surface (Figure 1A). Further endoscopic ultrasonography showed that the mass was 3.92 cm × 2.66 cm, originating from submucosa, with mixed echo, clear demarcation, and intact muscularis propria (Figure 1B). Enhanced chest CT also showed a 4.3 cm × 3.2 cm × 10.7 cm mass at the esophageal wall (Figure 1C). Endoscopic submucosal dissection (ESD) of the mass was performed after the patient's consent. Under general anesthesia and intubation, standard ESD procedures were performed (Video S1) with dual knife and insulated tip knife. En bloc resection of the mass was successful, without perforation or bleeding (Figure 1D–F). The attempt to retrieve the whole mass failed. Therefore, we fragmented the mass and retrieved them using a snare (Figure 1G,H). The wound was finally closed with titanium clips (Figure 1I). The entire procedural time was 104 min. The resected mass (Figure 2A) was pathologically diagnosed as mature teratoma (Figure 2B). No residue or recurrence of the tumor was found upon visit (Figure 2C). Mediastinal teratoma are frequently reported [<span>1</span>], but esophageal teratoma is rare [<span>2</span>]. Usually, patients may be referred to surgical or thoracoscopic resection for curative treatment. Considering the benign nature and clear demarcation of the mature teratoma, ESD is advantageous for its en bloc endoscopic resection. To the best of our knowledge, endoscopic management of giant esophageal teratoma has not been reported. Although the size of the tumor was over 40 mm and the whole procedural time was 104 min, posing risk of technical difficulty of ESD [<span>3</span>], the actual tumor dissection time was 9 min and the stalk size was 15 mm in our case, presenting no obvious resection limitation. Our case shows ESD is feasible for esophagus-derived teratoma, and therefore, may provide a safer, cheaper, and less invasive replacement of surgical interventions [<span>4</span>].</p><p>Yuhang Zhang drafted the manuscript and the video clip. Ruizhi Wang collected the material and made critical revisions. Bing Hu performed the endoscopic resection and conceptualization.</p><p>This work was supported by National Natural Science Foundation of China (82170675) and 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYJC21011).</p><p>Informed consent was obtained from the patient to publish these images.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 2","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70121","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digestive Endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1